Rolaids Line Expands Into Gas Relief With Multi-Symptom Extension
This article was originally published in The Tan Sheet
Executive Summary
Pfizer is positioning new Rolaids Multi-Symptom line extension as handling gas as well as heartburn in comparison to GlaxoSmithKline's Tums in spots that broke November 17